We are 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate CAS:239463-85-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Product Description:
Product Name:
5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate CAS NO: 239463-85-5
Synonyms:
(R)-5-(2-aminopropyl)-1-(3-benzoyloxypropyl) Indoline-7-Carbonitrile Tartaric acid;
3-[5-[(2R)-2-aminopropyl]-7-cyano-2,3-dihydroindol-1-yl]propyl benzoate,(2R,3R)-2,3-dihydroxybutanedioic acid;
1-(3-benzoyloxypropyl)-7-cyano-5-(2-aminopropyl)-2,3-dihydroindole;
Chemical & Physical Properties:
Appearance: Powder
Assay :≥99.00%
Exact Mass: 513.211121
Safety Information:
Signal Word: Warning
Hazard Statements: H315; H319; H335
Precautionary Statements: P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501
5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-Dihydroxybutanedioate is an intermediate of Silodosin (S465000) which is an α1a-adrenoceptor antagonist and used in the treatment of benign prostatic hypertophy.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
Related Products:disodium,(3E)-3-[[2-methyl-4-[3-methyl-4-[[4-(4-methylphenyl)sulfonyloxyphenyl]diazenyl]phenyl]phenyl]hydrazinylidene]-5-(4-methylphenyl)sulfonyloxy-4-oxonaphthalene-2,7-disulfonate manufacturer | 1,3-difluoro-2-isothiocyanato-5-(2-((1s,4s)-4-propylcyclohexyl)ethyl)benzene supplier | Pentanethioic acid S-(2-carbamoyl-phenyl) ester producer.
Product Name | |
---|---|
3-ISOTHIOUREIDOPROPIONIC ACID Cas:5398-29-8 | View Details |
Lithium nitrate Cas:7790-69-4 | View Details |
N-ETHYLFORMAMIDE | View Details |